Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

FDA advisory panel denies approval for Genzyme's Sepracoat

May 8, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Positive phase III results from Hyal's actinic keratosis trial

April 28, 1997

Gliatech's ADCON-L to recieve expedited review by FDA

April 24, 1997

LifeCell reports clinical data on AlloDerm

April 23, 1997

Promising data reported from pilot trial of Lubricoat Gel for adhesions

April 17, 1997

Another minoxidil generic approved in U.S. for women

April 16, 1997

Generic minoxidil receives FDA approval

April 16, 1997

Faulding launches wound care line in Australia and New Zealand

April 15, 1997

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...